• By ICR Secretariat
  • Posted Wednesday, May 15, 2019

Prostate cancer mutation found to triple risk of death


The largest ever study of advanced prostate cancer genomics has revealed that men with mutations in the retinoblastoma gene in their tumours were more than three times as likely to die and nearly seven times as likely to relapse on standard treatments as those without the gene.